ポイントオブケア診断の市場規模、シェア、成長分析：製品タイプ別、サンプル別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

世界のポイントオブケア診断の市場規模は、2022年に476億4,000万米ドルとなり、予測期間（2024年～2031年）のCAGRは6.1%で、2023年の505億4,000万米ドルから、2031年までには811億7,000万米ドルに成長する見通しです。

ポイントオブケア診断（POCD）市場とは、患者の近くで、あるいは患者の診療現場で実施される医療検査を指し、臨床的な意思決定を支援するために通常数分以内に完了する迅速診断のカテゴリーに分類されます。この市場には、病院、診療所、外来診療センター、さらには在宅医療など、さまざまなヘルスケア現場のニーズに合わせたさまざまな診断機器や検査法の設計・製造が含まれます。POCDは、迅速な納期、中央検査室への依存度の低減、患者転帰の改善、コスト効率など、数多くの利点を提供します。POCD市場に影響を与える主要な要因としては、患者基盤の拡大、診断材料の増産、検査サービス需要の高まり、高齢化人口の増加などが挙げられます。疾患の早期発見・管理に対する意識の高まりもPOCDの発展を後押ししています。市場成長の主要な促進要因は、バイオセンサーと接続機能を備えたハンドヘルド／ポータブル機器を特徴とする技術進歩です。さらに、ラボオンチップ技術は、ポイントオブケア検査の精度、スピード、可用性を高め、市場拡大にさらに貢献しています。COVID-19のパンデミックは、特に迅速抗原検査と分子診断によって市場を大きく加速させ、それによってウイルス検出を向上させました。しかし、法的障壁、償還の問題、品質管理の懸念などの課題が市場の進展を妨げる可能性があります。このような課題にもかかわらず、世界のPOCD市場は、継続的な技術進歩、ヘルスケア分散化の傾向、個別化された効率的な医療診断に対する需要の高まりにより、大幅な成長を遂げようとしています。

目次

イントロダクション

• 調査の目的
• 定義
• 市場範囲

調査手法

• 情報調達
• 二次・一次情報源
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 市場概要見通し
• 供給需要動向分析
• セグメント別機会分析

市場力学と見通し

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• ポーターの分析

主要な市場の考察

• 技術分析
• 価格分析
• バリューチェーン分析
• サプライチェーン分析
• 市場のエコシステム
• スタートアップ分析
• 特許分析
• ケーススタディ分析
• 顧客と購買基準の分析
• 規制情勢
• イノベーションマトリクス
• 主要な投資分析
• 主要な成功要因
• 市場魅力度指数
• 競合の程度

ポイントオブケア診断市場：サンプル別

• 市場概要
• 血液サンプル
• 尿サンプル
• 鼻腔・咽頭スワブ
• その他のサンプル

ポイントオブケア診断市場：製品別

• 市場概要
• 血糖値モニタリング製品
  • ストリップ
  • メートル
  • ランセット・穿刺器具
• COVID-19検査製品
• 心臓代謝モニタリング製品
  • 心臓マーカー検査製品
  • 血液ガス / 電解質検査製品
  • HBA1C検査製品
• 感染症検査製品
  • HIV検査製品
  • 呼吸器感染症検査製品
  • C型肝炎検査製品
  • 医療関連感染検査製品
  • インフルエンザ検査製品
  • 熱帯病検査製品
  • 性感染症検査製品
  • 梅毒検査製品
  • 梅毒検査製品
  • クラミジア・トラコマティス検査製品
  • 単純ヘルペスウイルス（HSV）検査製品
  • 結核
  • クロストリジウム・ディフィシル感染症検査製品
  • その他の感染症検査製品
• 凝固モニタリング製品
  • PT / INR検査製品
  • ACT / APTTテスト製品
• 妊娠・生殖検査製品
  • 妊娠検査製品
  • 不妊検査製品
  • 腫瘍/がんマーカー検査製品
  • 尿検査製品
  • コレステロール検査製品
  • 血液検査製品
  • 薬物乱用検査製品
  • 甲状腺刺激ホルモン検査製品
  • 便潜血検査製品
  • その他の製品

ポイントオブケア診断市場：エンドユーザー別

• 市場概要
• 臨床検査室
• 外来診療施設・医師の診療所
• 薬局、小売クリニック、eコマースプラットフォーム
• 病院、救命救急センター、緊急治療センター
• 在宅医療・自己検査
• その他のエンドユーザー

ポイントオブケア診断市場規模：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • その他欧州地域
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ地域

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主要な市場企業が採用した戦略
• 市場における最近の活動
• 主要企業の市場シェア（2023年）

主要企業プロファイル

• Abbott Laboratories（US）
• Siemens Healthineers AG（Germany）
• Quidel Corporation（US）
• F. Hoffman-La Roche Ltd.（Switzerland）
• Danaher Corporation（US）
• Becton, Dickinson and Company（US）
• Chembio Diagnostics（US）
• EKF Diagnostics（UK）
• Trinity Biotech plc（Ireland）
• Instrumentation Laboratory（US）
• Nova Biomedical（US）
• PTS Diagnostics（US）
• Sekisui Diagnostics（US）
• Thermo Fisher Scientific（US）
• BioMerieux S.A.（France）
• Beckman Coulter, Inc.（US）
• Hologic, Inc.（US）
• Cepheid（US）
• Ortho Clinical Diagnostics（US）
• Bio-Rad Laboratories, Inc.（US）
• Trividia Health（US）
• Chembio Diagnostic Systems, Inc.（US）

Global Point of Care Diagnostics Market size was valued at USD 47.64 Billion in 2022 and is poised to grow from USD 50.54 Billion in 2023 to USD 81.17 Billion by 2031, at a CAGR of 6.1% during the forecast period (2024-2031).

The Point of Care Diagnostics (POCD) market refers to medical testing conducted close to or at the site of patient care, falling under the category of rapid diagnostics typically completed within minutes to aid in clinical decision-making. This market encompasses the design and manufacturing of a variety of diagnostic equipment and assays tailored to the needs of different healthcare settings, including hospitals, clinics, ambulatory care centers, and even homecare. Point-of-care diagnostics offer numerous advantages, such as quicker turnaround times, reduced reliance on centralized laboratories, improved patient outcomes, and cost efficiency. Key factors influencing the POCD market include an expanding patient base, increased production of diagnostic materials, rising demand for laboratory services, and a growing aging population. The heightened awareness of early disease detection and management also fuels the development of POCD. A major driver of market growth is technological advancement, featuring handheld/portable devices with biosensors and connectivity capabilities. Additionally, lab-on-a-chip technology enhances the accuracy, speed, and availability of point-of-care tests, further contributing to market expansion. The COVID-19 pandemic significantly accelerated the market, particularly through rapid antigen testing and molecular diagnostics, thereby improving viral detection. However, challenges such as legal barriers, reimbursement issues, and quality control concerns could hinder market progress. Despite these challenges, the global POCD market is poised for substantial growth, driven by continuous technological advancements, the trend toward healthcare decentralization, and the increasing demand for personalized and efficient medical diagnostics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Point of Care Diagnostics (POCD) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Point of Care Diagnostics (POCD) Market Segmental Analysis

Point of care diagnostics market is segmented based on Sample, Product, End Users, and Region. Based on Sample, the market is segmented as Blood Sample, Urine Sample, Nasal and Oropharyngeal Swabs Sample, And Other Samples. Based On Product, The Market Is Further Segmented Into Glucose Monitoring Products (Strips, Meters, Lancets & Lancing Devices), Covid-19 Testing Products, Cardiometabolic Monitoring Products (Cardiac Marker Testing Products, Blood Gas/Electrolyte Testing Products, Hba1c Testing Products), Infectious Disease Testing Products (HIV Testing Products, Respiratory Infection Testing Products, Hepatitis C Testing Products, Healthcare-associated Infection Testing Products, Influenza Testing Products, Tropical Disease Testing Products, Sexually Transmitted Disease Testing Products, Syphilis Testing Products, Syphilis Testing Products, Chlamydia Trachomatis Testing Products, Herpes Simplex Virus (HSV) tEsting Products, Tuberculosis, Clostridium Difficile Infection Testing Products, Other Infectious Disease Testing Products), Coagulation Monitoring Products (PT/INR Testing Products, ACT/APTT Testing Products), Pregnancy & Fertility Testing Products (Pregnancy Testing Products, Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Product, Drugs-of-abuse Testing Products, Thyroid-stimulating Hormone Testing Products, Fecal Occult Testing Products, Other Products. Based On End Users, Point Of Care Diagnostics Market Is Further Segmented into Clinical Laboratories, Ambulatory Care Facilities and Physicians Offices, Pharmacies, Retail Clinics, And E-commerce Platforms, Hospitals, Critical Care Centers, And Urgent Care Centers, Home Care Settings And Self-testing, Other End Users. Based on region, the market is segmented into North America, Asia-Pacific, Europe, Latin America, Middle East and Africa.

Drivers of the Global Point of Care Diagnostics (POCD) Market

Globally, there has been a significant rise in the prevalence of chronic diseases such as cardiovascular issues, diabetes, and various infectious diseases. One of the key factors driving the demand for point-of-care diagnostics during the forecast period is the increasing occurrence of these disorders. According to the United Nations, approximately 38 million people were living with HIV/AIDS in 2019, including 1.8 million children and 36.2 million adults. Additionally, human respiratory syncytial virus (RSV) is a common cause of respiratory tract infections. The global adult diabetic population is projected to reach 643 million by 2030 and 783 million by 2045. The substantial increase in the prevalence of diabetes and other chronic diseases worldwide has created a demand for rapid point-of-care diagnostics aimed at effectively managing these conditions. Consequently, the market is expected to experience positive growth globally.

Restraints in the Global Point of Care Diagnostics (POCD) Market

Due to a high number of pre- and post-analytical errors, point-of-care test results often do not align accurately with central lab procedures. Pre-analytical errors can arise from unsuitable indications for performing the test, inappropriate sampling times and techniques, inadequate information about patient conditions, and other factors such as fasting before functional tests or differences in posture during similar tests. Post-analytical errors include insufficient technical validation, incorrect result assignment, and data storage issues. Point-of-care testing is frequently used in emergency situations to aid clinical decision-making, often performed by nurses or clinical team members rather than physicians. These circumstances can lead to incorrect order and result documentation, potentially resulting in misdiagnoses and affecting the quality of patient care. Due to these concerns, patients and doctors may opt against point-of-care testing. This represents one of the most significant barriers to the increased adoption of point-of-care testing.

Market Trends of the Global Point of Care Diagnostics (POCD) Market

Major market participants are increasingly focusing on integrating new technologies, such as artificial intelligence, into the production of efficient point-of-care diagnostics. Innovations like lab-on-a-chip platforms, wearable technologies, and smartphone integration have led to significant advancements in point-of-care testing devices. This trend is paving the way for future transformations, with cloud-based intelligent systems offering numerous possibilities for further revolutions. The development of new diagnostic systems has been influenced by the miniaturization of chip technology, advancements in microfluidics, and innovative biosensors. Lab-on-a-chip technology, particularly in infectious disease detection, is a key driver of POCT. This technology enables the use of microbiological culture, enzyme-linked immunosorbent assays (ELISA), and polymerase chain reaction (PCR) directly at the point of care.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Value Chain Analysis
• Supply Chain Analysis
• Ecosystem of the Market
• Start-up Analysis
• Patent Analysis
• Case Study Analysis
• Customer & Buying Criteria Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Market Attractive Index
• Degree of Competition

Point of Care Diagnostic Market by Sample

• Market Overview
• Blood Samples
• Urine Samples
• Nasal & Oropharyngeal Swabs
• Other Samples

Point of Care Diagnostic Market by Product

• Market Overview
• Glucose Monitoring Products
  • Strips
  • Meters
  • lancets & lancing devices
• Covid-19 Testing Products
• Cardiometabolic Monitoring Products
  • Cardiac Marker Testing Products
  • Blood Gas/Electrolyte Testing Products
  • HBA1C Testing Products
• Infectious Disease Testing Products
  • HIV Testing Products
  • Respiratory Infection Testing Products
  • Hepatitis C Testing Products
  • Healthcare-Associated Infection Testing Products
  • Influenza Testing Products
  • Tropical Disease Testing Products
  • Sexually Transmitted Disease Testing Products
  • Syphilis testing products
  • Syphilis testing products
  • Chlamydia trachomatis testing products
  • Herpes simplex virus (HSV) testing products
  • Tuberculosis
  • Clostridium Difficile Infection Testing Products
  • Other Infectious Disease Testing Products
• Coagulation Monitoring Products
  • PT/INR Testing Products
  • ACT/APTT Testing Products
• Pregnancy & Fertility Testing Products
  • Pregnancy Testing Products
  • Fertility Testing Products
  • Tumor/Cancer Marker Testing Products
  • Urinalysis Testing Products
  • Cholesterol Testing Products
  • Hematology Testing Products
  • Drugs-Of-Abuse Testing Products
  • Thyroid-Stimulating Hormone Testing Products
  • Fecal Occult Testing Products
  • Other Products

Point of Care Diagnostic Market by End User

• Market Overview
• Clinical Laboratories
• Ambulatory Care Facilities and Physicians Offices
• Pharmacies, Retail Clinics, And E-Commerce Platforms
• Hospitals, Critical Care Centers, And Urgent Care Centers
• Home Care Settings and Self-Testing
• Other End Users

Point of Care Diagnostic Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quidel Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffman-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chembio Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EKF Diagnostics (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Instrumentation Laboratory (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nova Biomedical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PTS Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trividia Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chembio Diagnostic Systems, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments